IP Library Patent Application 17047411
Patent Application
App. No. 17/047,411

METHODS AND COMPOSITIONS FOR FORMULATING AND DISPENSING PHARMACEUTICAL FORMULATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/047,411
Abstract

The present disclosure relates to use of specialized vessels for formulating and dispensing pharmaceutical formulations. The vessels are optionally able to maintain homeostatic conditions and a homogeneous constitution of pharmaceutical suspensions, while simultaneously dispensing them into single-use containers.

Claims (41)

1 . A method of formulating a pharmaceutical product comprising an active agent, said active agent comprising living cells, the method comprising:

a. introducing an initial liquid formulation, comprising said active agent, into a container;

b. agitating said initial liquid formulation;

c. determining a concentration of said living cells, enabling calculation of an amount of dilution solution necessary to achieve a target concentration of said living cells; and

d. adding said amount of said dilution solution to said initial liquid formulation, thereby generating a final formulation,

e. repeatedly removing a predetermined volume of said final formulation from said container,

wherein steps a-e are performed in said container; and said container is operably connected to:

(i) a portal for aseptic transfer of said dilution solution into said container;

(ii) a portal for aseptic transfer of said predetermined volume of said final formulation out of said container; and

(iii) an apparatus for controlling temperature inside said container.

2 . The method of claim 1 , wherein said living cells are in a suspension, and wherein said container is operably connected to a sensor for determining concentration of said living cells in said suspension.

3 . (canceled)

4 . The method of claim 1 , wherein said container is operably connected to a sensor for measuring viability of said living cells.

5 . The method of claim 1 , wherein said container is operably connected to (a) sensor for monitoring pH of said initial liquid formulation and means of controlling said pH; and (b) a sensor for monitoring dissolved oxygen concentration inside said container and an oxygen pump for controlling said dissolved oxygen concentration.

6 . (canceled)

7 . The method of claim 1 , wherein said container is operably connected to a first sensor for collecting data on conditions inside said container; and a second sensor for collecting data on transfer of fluid into and/or out of said container.

8 . (canceled)

9 . The method of claim 1 , wherein said container is operably connected to a pump for controlling a flow rate of fluid material transferred into said container.

10 . The method of claim 1 , further comprising mixing said final formulation with an agitation device, wherein said agitation device comprises a rotatable axial rod and blades connected to its bottom, and wherein said blades have a diameter less than widest diameter of said container.

11 . (canceled)

12 . The method of claim 1 , wherein said portal for aseptic transfer of said predetermined volume of said final formulation out of said container utilizes an aperture at a bottom of said container.

13 . The method of claim 1 , wherein said container further comprises a baffle that juts inward from an inward surface thereof.

14 . The method of claim 1 , further comprising a pump for controlling a flow rate of removal of said fluid material removed from said container.

15 . The method of claim 1 , wherein said method is aseptic.

16 . The method of claim 1 , further comprising repeating the step of determining a concentration of said living cells, after removal of some of said final formulation from said container.

17 . An enclosed system, comprising a receptacle, wherein:

a. said receptacle comprises an initial liquid formulation, said initial liquid formulation comprising a liquid vehicle and an active agent, said active agent comprising living cells;

b. said system is configured for agitating said initial liquid formulation;

c. said system is configured for determining concentration of said living cells;

d. said receptacle is further operably connected with a conduit for aseptically introducing a dilution solution into said receptacle, thereby generating a final formulation;

e. said receptacle is temperature-controlled; and

f. said receptacle is further operably connected with a conduit for repeatedly removing a predetermined volume of said final formulation from said container.

18 . The enclosed system of claim 17 , wherein said living cells are in a suspension.

19 . The enclosed system of claim 18 , wherein said receptacle is further operably connected to a sensor for determining concentration of said living cells in said suspension.

20 . The enclosed system of claim 17 , wherein said receptacle is further operably connected to a sensor for measuring viability of said living cells.

21 - 25 . (canceled)

26 . The enclosed system of claim 17 , wherein said system is configured for mixing said final formulation with an agitation device, wherein said agitation device comprises a rotatable axial rod and blades connected to its bottom, and wherein said blades have a diameter less than a widest diameter of said container.

27 . (canceled)

28 . The enclosed system of claim 17 , wherein repeatedly removing a predetermined volume of said final formulation utilizes an aperture at a bottom of said container.

29 . The enclosed system of claim 17 , wherein said system is sterile.

30 . The enclosed system of claim 17 , wherein said container further comprises a baffle that juts inward from an inward surface thereof.

Assignments (2)
CHANGE OF NAME Recorded Dec 30, 2022
From: PLURISTEM LTD.
To: PLURI BIOTECH LTD.
Reel/Frame 062247/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2021
From: RAVIV, LIOR; ESHKOL, NADAV; ROBERMAN, DORINA
To: PLURISTEM LTD.
Reel/Frame 058189/0346 →